“Selective” sounds reassuring, but it describes a particular experimental comparison. The original ipamorelin pharmacology paper tested growth-hormone release and several other hormones in laboratory and animal models. It did not establish that every possible effect or risk was absent.
The result in rat pituitary cells
Ipamorelin stimulated growth-hormone release from primary rat pituitary cells. The reported half-maximal concentration was 1.3 ± 0.4 nmol/L, compared with 2.2 ± 0.3 nmol/L for GHRP-6. The maximal responses were also reported separately. A lower half-maximal concentration describes potency within that test, not a broader clinical advantage.
Which selectivity was examined?
In swine, the authors compared growth-hormone effects with other hormone responses. They reported that ipamorelin did not raise ACTH or cortisol significantly above the levels observed with GHRH stimulation, even at high tested exposure relative to its growth-hormone response. This is a specific comparison in an animal experiment, not a general human safety guarantee.
Why “no significant difference” has a limit
A study can fail to detect a difference without proving that the true difference is exactly zero. Sample size, measurement timing and the tested exposure range all affect the conclusion. Long-term outcomes and different populations need their own evidence.
Useful questions for a research comparison
Keep the species, cell type, response measure and comparator together. Do not use the cell concentration as a use recommendation. If ordering ipamorelin for analytical or receptor research, state the required molecular identity, terminal form and analytical documents. A later clinical or laboratory result should be evaluated on its own design rather than borrowing the original paper’s selectivity label.
Related materials and next steps
Explore the NHD catalogue records for Ipamorelin. Confirm the required molecular form, quantity and lot-document availability before relying on a listing for procurement. A catalogue record does not establish equivalence to a published study material.
Send the product or sequence, quantity and document requirements. For more background, browse the analytical methods guides and research glossary.
Sources and reading scope
Source links checked 5 October 2026. Research summaries use the accessible original abstract unless a full-text source is explicitly identified. Guidance documents and external supplier explanations are technical references, not NHD batch evidence or a claim of regulatory compliance. Any example introduced as hypothetical or teaching is a calculation, not a measured product result.
NHD catalogue materials are for qualified laboratory research, development and manufacturing enquiries. This article does not provide instructions for human or veterinary use.
Sources & editorial method
AI-assisted writing and source checks; conceptual illustrated cover.
1 linked records are listed in the references below. Read the editorial and AI-assistance policy.
How to interpret this article
Study results and labeled examples are separated. Original-source, arithmetic, readability and internal-link checks; no independent human peer review recorded.
Research-use boundary: Catalog materials discussed on this website are for laboratory research, development and manufacturing use only, not for human or veterinary use. This content is not medical advice and does not provide administration instructions.
Primary records and authoritative sources
- Original ipamorelin growth-hormone selectivity studyChecked 2026-10-05; source scope is identified in the article.
Continue with structured records
Move from this editorial analysis to the product identity, filtered evidence and controlled terminology behind it.
